Lakefront Biotherapeutics | GLPG - 営業利益





営業利益 変化する 日付
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Biogen USD 514.3M 128.8M 2026-03
Genmab DKK 260M 199M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 26.38M 2026-03
Hikma Pharmaceutical USD 348M 161M 2025-12
Incyte USD 324.17M 59.7M 2026-03
Merck EUR 1.05B 572M 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.75B 515M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03